605 related articles for article (PubMed ID: 10674367)
1. Alopecia areata is a T-lymphocyte mediated autoimmune disease: lesional human T-lymphocytes transfer alopecia areata to human skin grafts on SCID mice.
Gilhar A; Shalaginov R; Assy B; Serafimovich S; Kalish RS
J Investig Dermatol Symp Proc; 1999 Dec; 4(3):207-10. PubMed ID: 10674367
[TBL] [Abstract][Full Text] [Related]
2. Melanocyte-associated T cell epitopes can function as autoantigens for transfer of alopecia areata to human scalp explants on Prkdc(scid) mice.
Gilhar A; Landau M; Assy B; Shalaginov R; Serafimovich S; Kalish RS
J Invest Dermatol; 2001 Dec; 117(6):1357-62. PubMed ID: 11886495
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice.
Gilhar A; Ullmann Y; Berkutzki T; Assy B; Kalish RS
J Clin Invest; 1998 Jan; 101(1):62-7. PubMed ID: 9421466
[TBL] [Abstract][Full Text] [Related]
4. Mediation of alopecia areata by cooperation between CD4+ and CD8+ T lymphocytes: transfer to human scalp explants on Prkdc(scid) mice.
Gilhar A; Landau M; Assy B; Shalaginov R; Serafimovich S; Kalish RS
Arch Dermatol; 2002 Jul; 138(7):916-22. PubMed ID: 12071819
[TBL] [Abstract][Full Text] [Related]
5. Alopecia areata: autoimmunity--the evidence is compelling.
Kalish RS; Gilhar A
J Investig Dermatol Symp Proc; 2003 Oct; 8(2):164-7. PubMed ID: 14582666
[TBL] [Abstract][Full Text] [Related]
6. Transfer of alopecia areata in the human scalp graft/Prkdc(scid) (SCID) mouse system is characterized by a TH1 response.
Gilhar A; Landau M; Assy B; Ullmann Y; Shalaginov R; Serafimovich S; Kalish RS
Clin Immunol; 2003 Mar; 106(3):181-7. PubMed ID: 12706404
[TBL] [Abstract][Full Text] [Related]
7. Characterization of infiltrating T cells in human scalp explants from alopecia areata to SCID nude mice: possible role of the disappearance of CD8+ T lymphocytes in the process of hair regrowth.
Tsuboi H; Tanei R; Fujimura T; Ohta Y; Katsuoka K
J Dermatol; 1999 Dec; 26(12):797-802. PubMed ID: 10659500
[TBL] [Abstract][Full Text] [Related]
8. Autoimmunity: alopecia areata.
Hordinsky M; Ericson M
J Investig Dermatol Symp Proc; 2004 Jan; 9(1):73-8. PubMed ID: 14870990
[TBL] [Abstract][Full Text] [Related]
9. Alopecia areata: a tissue specific autoimmune disease of the hair follicle.
Gilhar A; Kalish RS
Autoimmun Rev; 2006 Jan; 5(1):64-9. PubMed ID: 16338213
[TBL] [Abstract][Full Text] [Related]
10. The potential role of cytokines and T cells in alopecia areata.
Hoffmann R
J Investig Dermatol Symp Proc; 1999 Dec; 4(3):235-8. PubMed ID: 10674373
[TBL] [Abstract][Full Text] [Related]
11. Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies.
Gilhar A; Schrum AG; Etzioni A; Waldmann H; Paus R
Autoimmun Rev; 2016 Jul; 15(7):726-35. PubMed ID: 26971464
[TBL] [Abstract][Full Text] [Related]
12. Alopecia areata. Autoreactive T cells are variably enriched in scalp lesions relative to peripheral blood.
Kalish RS; Johnson KL; Hordinsky MK
Arch Dermatol; 1992 Aug; 128(8):1072-7. PubMed ID: 1497361
[TBL] [Abstract][Full Text] [Related]
13. Gene array profiling and immunomodulation studies define a cell-mediated immune response underlying the pathogenesis of alopecia areata in a mouse model and humans.
Carroll JM; McElwee KJ; E King L; Byrne MC; Sundberg JP
J Invest Dermatol; 2002 Aug; 119(2):392-402. PubMed ID: 12190862
[TBL] [Abstract][Full Text] [Related]
14. iNKT cells ameliorate human autoimmunity: Lessons from alopecia areata.
Ghraieb A; Keren A; Ginzburg A; Ullmann Y; Schrum AG; Paus R; Gilhar A
J Autoimmun; 2018 Jul; 91():61-72. PubMed ID: 29680372
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the expression of cutaneous lymphocyte-associated antigen on the peripheral blood and cutaneous lymphocytes of alopecia areata patients.
Yano S; Nakamura K; Okochi H; Tamaki K
Acta Derm Venereol; 2002; 82(2):82-5. PubMed ID: 12125957
[TBL] [Abstract][Full Text] [Related]
16. SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction.
Gao Z; Jin YQ; Wu W
Oncotarget; 2017 May; 8(20):33432-33443. PubMed ID: 28418931
[TBL] [Abstract][Full Text] [Related]
17. Alopecia areata: A multifactorial autoimmune condition.
Simakou T; Butcher JP; Reid S; Henriquez FL
J Autoimmun; 2019 Mar; 98():74-85. PubMed ID: 30558963
[TBL] [Abstract][Full Text] [Related]
18. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study.
Simonetti O; Lucarini G; Bernardini ML; Simoncini C; Biagini G; Offidani A
Br J Dermatol; 2004 May; 150(5):940-8. PubMed ID: 15149507
[TBL] [Abstract][Full Text] [Related]
19. Oral cyclosporine for the treatment of alopecia areata. A clinical and immunohistochemical analysis.
Gupta AK; Ellis CN; Cooper KD; Nickoloff BJ; Ho VC; Chan LS; Hamilton TA; Tellner DC; Griffiths CE; Voorhees JJ
J Am Acad Dermatol; 1990 Feb; 22(2 Pt 1):242-50. PubMed ID: 2138175
[TBL] [Abstract][Full Text] [Related]
20. Diphenylcyclopropenone treatment of alopecia areata induces apoptosis of perifollicular lymphocytes.
Herbst V; Zöller M; Kissling S; Wenzel E; Stutz N; Freyschmidt-Paul P
Eur J Dermatol; 2006; 16(5):537-42. PubMed ID: 17101475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
